Patents by Inventor Uwe Loeffler

Uwe Loeffler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7825125
    Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.
    Type: Grant
    Filed: August 8, 2006
    Date of Patent: November 2, 2010
    Assignee: Helm AG
    Inventors: Katja Stritzke, Uwe Löffler, Klaus Glänzer
  • Patent number: 7799790
    Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: September 21, 2010
    Assignee: Helm AG
    Inventors: Katja Dreyer, Uwe Loeffler, Klaus Glaenzer
  • Publication number: 20080280921
    Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.
    Type: Application
    Filed: June 2, 2008
    Publication date: November 13, 2008
    Applicant: Helm AG
    Inventors: Katja Dreyer, Uwe Loeffler, Klaus Glaenzer
  • Publication number: 20080020038
    Abstract: Morphologically stabilized amorphous aripiprazole and process for preparing the same.
    Type: Application
    Filed: August 8, 2006
    Publication date: January 24, 2008
    Applicant: HELM AG
    Inventors: Katja Stritzke, Uwe Loeffler, Klaus Glaenzer
  • Publication number: 20050123607
    Abstract: The invention relates to a pharmaceutical formulation of valaciclovir or a pharmaceutically acceptable salt thereof and a process of preparing such formulation.
    Type: Application
    Filed: December 9, 2004
    Publication date: June 9, 2005
    Inventors: Sonja Lieb, Uwe Loeffler
  • Patent number: 5453280
    Abstract: A process for producing pellets which are markedly spherical and have a particle size in the range from 0.1 to 4 mm and an apparent density above 0.5 g/cm.sup.3, and which are composed of 90-100% by weight of an ephedrine derivative and 0-10% by weight of a pharmaceutical aid, entails suspending ephedrine derivative powder with an average particle size of from 0.5 to 50 .mu.m at 0.degree.-90.degree. C. with stirring in a water-immiscible non solvent with a boiling point in the range from 60.degree. to 160.degree. C., adding 5-60% by weight, based on the ephedrine derivative, of an agglomerating liquid while continuing stirring, and, if there has been previous heating, cooling to from -5 to 25.degree. C. at 5-40K per hour, with the stirring speed being adjusted after the agglomeration of the powder particles to a value which is necessary for the required average particle size, and removing and drying the resulting pellets.
    Type: Grant
    Filed: September 7, 1993
    Date of Patent: September 26, 1995
    Assignee: Nordmark Arzneimittel GmbH
    Inventors: Thomas Moest, Uwe Loeffler, Hans Waiblinger